Michael C Keifer

Title: Michael C. Keifer: Innovator in Fibroblast Growth Factor Research

Introduction

Michael C. Keifer is a notable inventor based in Clayton, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of fibroblast growth factor receptors. With a total of 3 patents, his work has implications for both therapeutic applications and research methodologies.

Latest Patents

Among his latest patents is a composition comprising polynucleotides encoding human fibroblast growth factor receptor and its uses. This innovation involves cloning and expressing a new receptor for fibroblast growth factor, which is useful for inhibiting FGF activity. Additionally, it allows for the screening of compounds that exhibit binding activity similar to that of FGF. Another significant patent focuses on the expression and use of the human fibroblast growth factor receptor, further emphasizing its utility in both therapeutic and research contexts.

Career Highlights

Michael C. Keifer has been associated with Chiron Corporation, where he has contributed to groundbreaking research and development in biotechnology. His work has not only advanced scientific understanding but has also paved the way for potential new treatments in medicine.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues such as Philip J. Barr and Pablo D. T. Valenzuela. These collaborations have enriched his research and expanded the impact of his innovations.

Conclusion

Michael C. Keifer's contributions to the field of fibroblast growth factor research highlight his role as a significant inventor in biotechnology. His patents and collaborations continue to influence the landscape of medical research and innovation.